查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863445

次世代定序(NGS)套件市場按產品類型、應用、最終用戶和定序技術分類－2025 年至 2032 年全球預測

NGS Kits Market by Product Type, Application, End User, Sequencing Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，次世代定序(NGS)套件市場將成長至 39.8 億美元，複合年成長率為 6.28%。

關鍵市場統計數據
基準年 2024 24.4億美元
預計年份：2025年 26億美元
預測年份 2032 39.8億美元
複合年成長率 (%) 6.28%

本書權威地介紹了定序套件在科學研究和臨床環境中建構穩健的基因組和轉錄組分析工作流程中所扮演的不斷演變的角色。

次世代定序套件是實現高解析度基因組、轉錄組和表觀基因分析的基礎工具，廣泛應用於科學研究、臨床和工業領域。這些套件包含將生物樣本轉化為定序文庫和模板所需的試劑、耗材和預處理流程，其性能特徵顯著影響下游資料的品質和可解釋性。隨著定序應用的日益多樣化，套件設計也在不斷發展，優先考慮靈活性、通量相容性和最少的操作時間，從而支持從標靶定序到全基因組分析等各種實驗設計。

在現代實驗室環境中，套件供應商面臨日益成長的重現性、法規合規性和與自動化平台整合的期望。因此，創新重點在於降低通訊協定的複雜性、提高試劑穩定性以及增強與多種儀器架構的兼容性。同時，終端用戶也需要透明的文件和強大的技術支持，以降低採用門檻。本文將定序套件置於整個基因組分析生命週期中進行分析，重點闡述了套件化學性質和工作流程便捷性的逐步改進如何累積累積影響實驗結果、採購決策，並促進生命科學價值鏈上的戰略夥伴關係。

了解化學、自動化和平台相容性的整合創新如何重新定義定序套件並重塑基因組學領域的實驗室工作流程。

由於化學、奈米孔和基於合成的讀通技術的平行發展，以及單細胞和長讀長定序應用的日趨成熟，定序套件領域正在經歷變革性的變化。傳統的定序工作流程著重於逐步提高讀長準確性和通量，而近期的進展已將重點轉向通用性和端到端工作流程的最佳化。例如，樣品製備變得更加模組化，使實驗室能夠在無需大幅重新開發通訊協定的情況下，客製化輸入樣本要求和富集策略。同時，模板製備和基於PCR的擴增方法的改進提高了定序結果的均一性並降低了偏差，尤其是在複雜基因組和低起始樣本的情況下。

此外，定序平台的演進正迫使套件製造商重新設計其試劑組合和相容性矩陣。新興的奈米孔化學技術和改進的定序序 (SBS) 方法需要客製化的文庫定序套件，以平衡儀器的特定限制和使用者對易用性的期望。這種技術多樣性促使套件開發商採用平台無關的設計，或加大與特定儀器生態系統的合作。同時，樣本追蹤、條碼和與生物資訊流程整合的數位化創新，正在改變使用者對試劑套件的期望，使其超越濕實驗室性能的範疇，從而形成一個試劑品質、軟體互通性和最終用戶體驗相互融合的競爭格局。

評估近期關稅變化對定序套件採購的韌性和供應商策略的影響，以及對營運和供應鏈的影響。

貿易政策的變化，包括關稅調整，對定序套件的採購和分銷動態產生重大影響，尤其對於那些跨境採購試劑、耗材和儀器相容配件的企業而言更是如此。關稅會改變到岸成本，促使企業重新評估其供應商組合，採用替代物流策略，或將部分生產活動在地化，以維持穩定的供應和可預測的價格。因此，採購團隊和業務負責人正在重新評估供應商協議，並探索合約機制以降低上行風險。同時，監管和海關合規團隊也在努力簡化文件流程，以避免貨物延誤。

為因應新的關稅制度，製造商可能會優先考慮區域性生產投資，或調整分銷佈局，以維持對臨床和研究客戶的服務水準。這些策略調整可能導致前置作業時間變化、最低訂購量要求調整以及區域售後服務安排變更。重點，關稅帶來的成本壓力將影響整個價值鏈，促使相關人員簡化套件配方、簡化包裝並最佳化托盤堆疊以提高運輸效率。這些營運獎勵凸顯了在供應鏈韌性規劃方面開展合作的必要性，以及在貿易政策波動時期與最終用戶建立透明溝通管道以管理預期的重要性。

將產品類型、應用需求、最終用戶畫像和定序技術與策略性套件設計和部署聯繫起來的綜合細分分析

詳細的細分闡明了定序套件生態系統的產品組合和使用者需求。產品類型分為樣品製備套件、定序套件和模板製備試劑套件，其中樣品製備盒又細分為擴增子特異性套件、RNA定序最佳化試劑套件和套件定序套件合成定序方法和奈米孔導引化學方法，奈米孔方法本身又分為生物奈米孔試劑和固體相奈米孔試劑。模板製備流程涵蓋橋接PCR和乳液PCR兩種方法，每種方法都會影響通量和應用範圍。

我們基於應用領域的分類闡明了套件如何滿足特定的分析目標，涵蓋從EXOME和標靶定序到轉錄組和全基因組分析等應用情境。EXOME通訊協定因臨床級和研究級應用而異，標靶策略包括基於雜合反應的富集和PCR驅動的標靶選擇。轉錄組定序包括批量RNA定序和單細胞RNA定序，每種方法對輸入處理和擴增精確度都有不同的要求。我們的最終用戶細分突出了學術研究機構、臨床診斷實驗室以及製藥和生物技術公司之間操作需求的差異，並進一步強調了這些類別內部的細微差別（例如，政府研究中心與大學實驗室、醫院診斷機構與獨立檢測實驗室以及新興生物技術公司與成熟的全球製藥公司）。最後，我們的定序技術細分區分了核心平台——奈米孔定序、連接定序和合成定序——並進一步細分了生物奈米孔定序和固體奈米孔定序。這些因素會影響套件化學設計選擇和工作流程整合策略。

採用這些細分觀點可以明確產品設計、監管合規和服務模式必須如何與應用和最終用戶的具體需求保持一致，從而使製造商和經銷商能夠優先考慮與目標客戶群體產生共鳴的產品藍圖和技術支援服務。

區域戰略觀點：整合美洲、歐洲、中東和非洲以及亞太市場的監管、基礎設施和採購現狀

在三大關鍵區域，區域趨勢正在塑造定序套件的需求模式、法規要求和供應鏈結構。在美洲，強大的學術網路和成熟的臨床診斷市場推動了對注重合規性、可重複性和與現有儀器基礎設施整合的套件的需求。採購流程受到機構採購週期和關鍵試劑國內生產能力的影響，因此，及時的技術支援和檢驗的通訊協定是至關重要的採購標準。

歐洲、中東和非洲地區（EMEA）監管環境的多樣性和研究基礎設施的異質性，既給套件供應商帶來了挑戰，也帶來了機會。協調統一的措施和跨區域臨床網路的建​​立，推動了對具備完善文件、多語言技術資源以及本地檢驗、可適應的工作流程的套件的需求。此外，該地區多個市場正在湧現新興生物技術中心，加速了先進定序方法的應用，迫使供應商提供靈活的供應安排和在地化的培訓計畫。

亞太地區基因組研究能力的快速發展和臨床定序的日益普及，推動了對可擴展性強、適用於大規模操作、同時兼具成本效益和在不同實驗室環境下穩健性的套件的需求。在地化生產措施和政府支持的研發項目進一步鼓勵供應商建立區域中心、聯合開發夥伴關係和本地化品質體系，以滿足監管要求並加快市場准入。總而言之，區域性因素凸顯了製定具有地理意識的產品策略和供應鏈模式的必要性，這些策略和模式需要應對不同的法規環境、基礎設施條件和商業性現實。

關鍵的競爭策略和企業策略將透過產品組合整合、供應鏈韌性和端到端解決方案交付來決定成敗。

在定序套件領域，企業策略越來越取決於其產品組合的廣度、技術支援的深度以及提供整合工作流程的能力，從而降低採用門檻。領先的套件開發商優先考慮與多種定序平台的兼容性，同時投資於配方改進，以延長保存期限並降低通訊協定的複雜性。與儀器製造商、自動化供應商和生物資訊解決方案供應商建立策略聯盟，透過創建滿足濕實驗室和數據驅動需求的端到端解決方案，進一步提升了價值提案。

除了產品創新之外，競爭優勢還來自於供應鏈的可靠性以及大規模提供檢驗的通訊協定和培訓的能力。那些維護透明的品質系統、提供快速回應的技術服務和清晰文件的公司，更受診斷實驗室和大型研究聯盟的青睞，因為這些機構將可重複性和法規遵循放在首位。此外，透過將試劑生產與耗材製造和分銷相結合來實現垂直整合的公司，可以提供捆綁式解決方案，從而簡化採購並支援生命週期管理。最後，專注於模組化套件設計和針對特定應用場景的最佳化，使公司能夠滿足各種不同的使用場景，同時最大限度地減少對大量庫存SKU的需求，從而實現營運效率和以客戶為中心的客製化服務。

為製造商和供應商提供切實可行的策略建議，以加速將定序套件整合到複雜的實驗室工作流程中，提高應用率，並增強韌性。

產業領導者可以採取實際行動來鞏固市場地位，並應對技術和政策變化。首先，優先考慮供應鏈多元化，並為關鍵試劑和耗材建立雙重採購管道，可以降低貿易中斷的風險。區域製造投資還可以縮短前置作業時間，提高服務應對力。其次，投資於模組化套件架構和自動化平台的標準化介面，可以擴大目標客戶群，並降低高通量實驗室的整合門檻。

第三，積極與監管機構和臨床相關人員合作，開發檢驗且文件齊全的套件產品，可以加速其在診斷領域的應用，並建立採購決策者的信任。第四，深化與設備和軟體合作夥伴的合作，提供檢驗的端到端工作流程，可以創造超越銷售點的強大價值提案。最後，建立完善的售後支援體系，包括實踐培訓、通訊協定最佳化服務和快速技術支援，可以提高客戶維繫，並使製造商能夠透過回饋循環進行迭代創新，從而實現以客戶需求主導的產品改進。

我們採用穩健的混合調查方法，結合關鍵相關人員對話、技術檢驗和供應鏈分析，為決策者提供可操作且可靠的見解。

本研究綜合運用了多層次的調查方法，結合了與關鍵相關利益者的直接對話、嚴謹的二手資料分析和技術檢驗。初步研究包括對實驗室主任、採購負責人、產品經理和法規事務專家進行深入訪談，以收集有關營運重點、挑戰和推廣促進因素的第一手資訊。此外，還對技術文獻、法規指導文件和產品規格進行了全面審查，以準確了解套件的化學成分、工作流程依賴性和合規性考量，從而補充了這些定性資訊。

為了補充定性研究結果，我們納入了產品系列映射、專利格局評估和供應鏈可追溯性分析，以識別通用的製造依賴關係和分銷模式。透過將供應商通訊協定的性能聲明與獨立實驗室報告和用戶回饋進行交叉核對，實現了技術檢驗；同時，專家小組的審查為分類和戰略意義提供了額外的考慮。在整個調查方法中，我們強調三角驗證和透明度，以確保結論反映的是多方面的證據，而非單一來源的斷言，從而提出基於實際運作情況的切實可行的建議。

總結觀點：明確相關人員在定序套件創新、監管和供應鏈複雜性方面應重點關注的策略事項

摘要，定序套件在實現高品質基因組和轉錄組分析方面發揮著至關重要的作用，隨著應用領域和平台的日益多元化，其策略重要性也與日俱增。能夠根據特定應用需求調整產品設計、投資加強供應鏈韌性並提供與自動化和資料工作流程檢驗整合方案的製造商和經銷商，將更有利於滿足科學研究和臨床客戶不斷變化的需求。鑑於政策和貿易的發展，靈活的籌資策略和透明的溝通對於降低中斷風險至關重要。

展望未來，最成功的機構將把套件化學和工作流程的快速創新與對可重複性、法規合規性和上市後支持的不懈追求相結合。這不僅能夠解決當前的營運限制，還能使實驗室採用更具挑戰性的實驗設計，並推動科學和臨床進步。這個結論凸顯了一項策略要務，它應指導整個定序套件生態系統的研發優先排序、商業規劃和客戶參與。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將自動化微流體和機器人技術整合到NGS套件中，用於高通量臨床診斷
  • 採用基於 CRISPR 的靶向序列捕獲NGS套件提高罕見突變檢測靈敏度
  • 擴展單細胞定序NGS套件，以實現單細胞層級上的同步多體學學分析
  • 推出攜帶式奈米孔定序NGS套件，用於遠端即時基因組監測
  • 開發一種經濟高效的多重NGS套件，該試劑盒針對大規模人群基因組篩檢進行了最佳化。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章次世代定序(NGS)套件市場（依產品類型分類）

  • 樣品製備套件
    • 擴增子庫套件
    • RNA-Seq文庫建構試劑套件
    • 全基因組文庫建構試劑套件
  • 定序套件
    • 奈米孔定序套件
      • 生物奈米孔套件
      • 固態奈米孔套件
    • 合成定序試劑套件
  • 模板準備套件
    • 橋接PCR套件
    • 乳液PCR套件

第9章 依應用分類的次世代定序(NGS)套件市場

  • EXOME定序
    • 臨床EXOME定序
    • 研究EXOME定序
  • 標靶定序
    • 基於雜合反應的標靶定序
    • 基於PCR的標靶定序
  • 轉錄定序
    • 批量RNA測序
    • 單細胞RNA定序
  • 全基因測序

第10章 依最終用戶分類的次世代定序(NGS)套件市場

  • 學術研究機構
    • 政府研究所
    • 大學研究所
  • 臨床實驗室
    • 醫院診斷實驗室
    • 獨立診斷實驗室
  • 製藥和生物技術公司
    • 生技Start-Ups
    • 全球製藥公司

第11章 依定定序技術分類的次世代定序(NGS)套件市場

  • 奈米孔定序
    • 生物奈米孔
    • 固態奈米孔
  • 連接定序
  • 合成定定序

第12章 各地區次世代定序（NGS）套件市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章次世代定序(NGS)套件市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國次世代定序（NGS）套件市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • Roche Holding AG
    • Danaher Corporation
    • MGI Tech Co., Ltd.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Takara Bio Inc.
    • Oxford Nanopore Technologies plc
    • Twist Bioscience Corporation
Product Code: MRR-5C6F41F5AFEA

The NGS Kits Market is projected to grow by USD 3.98 billion at a CAGR of 6.28% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.44 billion
Estimated Year [2025] USD 2.60 billion
Forecast Year [2032] USD 3.98 billion
CAGR (%) 6.28%

An authoritative introduction to the evolving role of sequencing kits in enabling robust genomic and transcriptomic workflows across research and clinical environments

Next-generation sequencing kits are foundational tools that enable high-resolution genomic, transcriptomic and epigenomic analysis across research, clinical and industrial settings. These kits encompass reagents, consumables and preparative workflows that convert biological samples into sequencing-ready libraries and templates, and their performance characteristics materially influence downstream data quality and interpretability. As sequencing applications diversify, kit design has evolved to prioritize flexibility, throughput compatibility and minimized hands-on time, supporting a broader range of experimental designs from targeted panels to whole genome interrogation.

Across contemporary laboratory ecosystems, kit providers face escalating expectations for reproducibility, regulatory readiness and integration with automated platforms. Consequently, innovation has concentrated on reducing protocol complexity, improving reagent stability and enabling compatibility with multiple instrument architectures. At the same time, end users demand transparent documentation and robust technical support to reduce adoption friction. This introduction situates sequencing kits within the broader lifecycle of genomic assays, emphasizing how incremental improvements in kit chemistry and workflow ergonomics cumulatively shape experimental outcomes, influence purchasing decisions and inform strategic partnerships across the life sciences value chain.

How converging innovations in chemistry, automation and platform compatibility are redefining sequencing kits and reshaping laboratory workflows across genomics

The landscape for sequencing kits is undergoing transformative shifts driven by concurrent advances in chemistry, nanopore and synthesis-based readout technologies, and the maturation of single-cell and long-read applications. Historically, sequencing workflows emphasized incremental gains in read accuracy and throughput, but recent progress has pivoted attention toward versatility and end-to-end workflow optimization. For example, library preparation has become more modular, enabling labs to tailor input requirements and enrichment strategies without extensive protocol redevelopment. In parallel, improvements in template preparation and PCR-based amplification approaches have enhanced uniformity and reduced bias, particularly for complex genomes and low-input samples.

Moreover, sequencing platform evolution is prompting kit manufacturers to reimagine reagent sets and compatibility matrices. Emergent nanopore chemistries and enhanced sequencing-by-synthesis formulations require bespoke library and sequencing kits that reconcile instrument-specific constraints with user expectations for ease of use. This technological plurality encourages kit developers to adopt platform-agnostic designs or to invest in tight integration with specific instrument ecosystems. At the same time, digital innovations in sample tracking, barcoding and integration with bioinformatics pipelines are transforming what users expect from a kit beyond wet-lab performance, creating a competitive landscape where reagent quality, software interoperability and end-user experience converge.

Assessing the operational and supply chain consequences of recent tariff shifts and their implications for procurement resilience and supplier strategies in sequencing kits

Trade policy shifts, including tariff adjustments, exert a tangible influence on the procurement and distribution dynamics for sequencing kits, particularly for organizations that source reagents, consumables and instrument-compatible accessories across borders. Tariffs alter landed costs and create incentives for firms to reassess supplier portfolios, adopt alternative logistics strategies, or localize certain manufacturing activities to maintain reliable supply and predictable pricing. As a result, procurement teams and commercial leaders are re-evaluating supplier contracts and exploring contractual mechanisms to mitigate exposure to abrupt cost escalations, while regulatory and customs compliance functions are intensifying documentation practices to avoid shipment delays.

In response to new tariff regimes, manufacturers may prioritize regional manufacturing investments or adjust their distribution footprints to preserve service levels for clinical and research customers. These strategic adjustments can lead to modified lead times, revised minimum order requirements and changes in how after-sales support is structured across territories. Importantly, tariff-driven cost pressures also affect the entire value chain, creating incentives for stakeholders to streamline kit formulations, reduce packaging complexity and optimize palletization to lower transportation inefficiencies. These operational adaptations underscore the need for coordinated supply chain resilience planning and the importance of establishing transparent communication channels with end users to manage expectations during periods of trade policy volatility.

Comprehensive segmentation insights that map product types, application demands, end-user profiles and sequencing technologies to strategic kit design and deployment

Detailed segmentation provides clarity on the distinct product configurations and user requirements that define the sequencing kits ecosystem. Product type distinctions separate library preparation kits, sequencing kits and template preparation kits, with library preparation further differentiating amplicon-focused kits, RNA sequencing optimized kits and whole genome library solutions. Sequencing kit varieties include nanopore-oriented chemistries alongside sequencing-by-synthesis formulations, and the nanopore category itself splits into biological nanopore reagents and solid-state implementations. Template preparation workflows capture both bridge PCR and emulsion PCR approaches, each with implications for throughput and application suitability.

Application-based segmentation frames how kits are tailored to specific analytical goals, ranging from exome and targeted sequencing use cases to transcriptome analyses and whole genome interrogation. Exome protocols vary between clinical-grade and research-focused implementations, while targeted strategies encompass hybridization-based enrichment as well as PCR-driven target selection. Transcriptome sequencing includes both bulk RNA and single-cell RNA methodologies, each driving distinct requirements for input handling and amplification fidelity. End-user segmentation emphasizes the different operational demands of academic research institutes, clinical diagnostic laboratories and pharmaceutical or biotechnology companies, and highlights nuance within these categories such as government research centers versus university laboratories, hospital diagnostic facilities versus independent labs, and the distinctions between startup biotechnology firms and established global pharmaceutical companies. Finally, sequencing technology segmentation differentiates core platforms including nanopore, sequencing by ligation and sequencing by synthesis, with further granularity between biological and solid-state nanopore implementations, which influence kit chemistry choices and workflow integration strategies.

Taken together, these segmentation lenses clarify how product design, regulatory readiness and service models must be aligned to the specific needs of applications and end users, enabling manufacturers and distributors to prioritize product roadmaps and technical support offerings that resonate with their target customer segments.

Regional strategic perspectives that reconcile distinct regulatory, infrastructure and procurement realities across Americas, Europe Middle East and Africa and Asia Pacific markets

Regional dynamics shape demand patterns, regulatory requirements and supply chain architectures for sequencing kits across three primary geographies. In the Americas, robust academic networks and a mature clinical diagnostics market drive demand for kits that emphasize regulatory compliance, reproducibility and integration with established instrument bases. Procurement processes are influenced by institutional purchasing cycles and the presence of domestic manufacturing capacity for key reagents, creating a context in which timely technical support and validated protocols are decisive purchasing criteria.

Across Europe, Middle East & Africa, diverse regulatory landscapes and heterogeneous research infrastructures create both challenges and opportunities for kit providers. Harmonization efforts and pan-regional clinical networks increase the appeal of kits with strong documentation, multilingual technical resources and adaptable workflows that can be validated locally. Additionally, emerging biotech hubs in several markets within this region are accelerating adoption of advanced sequencing approaches, prompting suppliers to offer flexible supply arrangements and localized training programs.

In the Asia-Pacific region, rapid expansion of genomic research capabilities and increasing clinical sequencing penetration favor kits that can scale across high-volume operations while remaining cost-effective and robust in varied laboratory settings. Local manufacturing initiatives and government-supported research programs further incentivize suppliers to establish regional presences, co-development partnerships and localized quality systems to meet regulatory expectations and expedite market entry. Collectively, regional considerations underscore the need for geographically informed product strategies and supply chain models that accommodate differing regulatory, infrastructural and commercial realities.

Key competitive dynamics and corporate strategies that determine success through portfolio integration, supply chain resilience and end to end solution offerings

Company strategies within the sequencing kits arena are increasingly defined by portfolio breadth, depth of technical support and the ability to offer integrated workflows that reduce barriers to adoption. Leading kit developers emphasize compatibility with multiple sequencing platforms while investing in formulation improvements that enhance shelf life and reduce protocol complexity. Strategic partnerships with instrument manufacturers, automation vendors and bioinformatics solution providers further extend value propositions by creating end-to-end solutions that address both wet-lab and data-driven needs.

In addition to product innovation, competitive differentiation arises from supply chain reliability and the capacity to deliver validated protocols and training at scale. Companies that maintain transparent quality systems, responsive technical service and clear documentation gain traction among diagnostics laboratories and large research consortia that prioritize reproducibility and regulatory readiness. Moreover, where companies pursue vertical integration-combining reagent production with consumable manufacturing and distribution-they can offer bundled solutions that simplify procurement and support lifecycle management. Finally, an emphasis on modular kit design and application-specific optimization enables firms to capture diverse use cases while minimizing the need for extensive inventory SKUs, supporting both operational efficiency and customer-focused customization.

Actionable strategic recommendations for manufacturers and providers to enhance resilience, broaden adoption and accelerate integration of sequencing kits into complex laboratory workflows

Industry leaders can take concrete actions to strengthen market position and respond to both technological and policy-driven shifts. First, prioritizing supply chain diversification and establishing dual-sourcing arrangements for critical reagents and consumables will reduce vulnerability to trade disruptions, while regional manufacturing investments can shorten lead times and enhance service responsiveness. Second, investing in modular kit architectures and standardized interfaces for automation platforms will broaden addressable customer segments and lower barriers to integration for high-throughput laboratories.

Third, engaging proactively with regulatory bodies and clinical stakeholders to develop validated, documentation-rich kit offerings will accelerate adoption in diagnostic settings and build trust among procurement decision-makers. Fourth, deepening collaboration with instrument and software partners to deliver verified end-to-end workflows will create compelling value propositions that go beyond single-product sales. Finally, cultivating robust post-sale support, including hands-on training, protocol optimization services and rapid technical escalation pathways, will increase customer retention and enable manufacturers to capture customer-driven product improvements through feedback loops that inform iterative innovation.

A robust mixed methodology combining primary stakeholder engagement, technical validation and supply chain analysis to produce practical and reliable insights for decision makers

This research synthesizes insights from a layered methodology that combines primary stakeholder engagement with rigorous secondary analysis and technical validation. Primary research included in-depth interviews with laboratory directors, procurement specialists, product managers and regulatory affairs professionals to capture first-hand perspectives on operational priorities, pain points and adoption drivers. These qualitative inputs were complemented by a comprehensive review of technical literature, regulatory guidance documents and product specification sheets to ensure accurate representation of kit chemistries, workflow dependencies and compliance considerations.

To augment qualitative findings, the analysis incorporated product portfolio mapping, patent landscape assessment and supply chain tracing to identify common manufacturing dependencies and distribution models. Technical validation was achieved through cross-referencing vendor protocol performance claims with independent experimental reports and user feedback, while expert panel reviews provided additional scrutiny of categorizations and strategic implications. Throughout the methodology, emphasis was placed on triangulation and transparency to ensure that conclusions reflect convergent evidence rather than single-source assertions, enabling practical recommendations that are grounded in operational realities.

Concluding perspectives that crystallize the strategic priorities for stakeholders to navigate innovation, regulation and supply chain complexity in sequencing kits

In sum, sequencing kits occupy a pivotal role in enabling high-quality genomic and transcriptomic assays, and their strategic importance is increasing as applications diversify and platform plurality expands. Manufacturers and distributors who align product design with application-specific needs, invest in supply chain resilience, and offer verifiable integration with automation and data workflows will be best positioned to meet the evolving expectations of research and clinical customers. Policy and trade developments underscore the need for flexible sourcing strategies and transparent communication to mitigate disruption risks.

Looking ahead, the most successful organizations will balance rapid innovation in kit chemistries and workflows with a relentless focus on reproducibility, regulatory alignment and post-sale support. By doing so, they can not only address current operational constraints but also enable laboratories to adopt more ambitious experimental designs that drive scientific and clinical advances. This conclusion highlights the strategic imperatives that should guide R&D prioritization, commercial planning and customer engagement across the sequencing kits ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of automated microfluidics and robotics in NGS kits for high-throughput clinical diagnostics
  • 5.2. Adoption of CRISPR-based target enrichment NGS kits to enhance rare variant detection sensitivity
  • 5.3. Expansion of single-cell sequencing NGS kits enabling simultaneous multiomic profiling at single-cell level
  • 5.4. Emergence of portable nanopore-based NGS kits facilitating real-time genomic surveillance in remote settings
  • 5.5. Development of cost-effective multiplexed NGS kits optimized for large-scale population genomic screening

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Kits Market, by Product Type

  • 8.1. Library Preparation Kits
    • 8.1.1. Amplicon Library Kits
    • 8.1.2. RNA-Seq Library Kits
    • 8.1.3. Whole Genome Library Kits
  • 8.2. Sequencing Kits
    • 8.2.1. Nanopore Sequencing Kits
      • 8.2.1.1. Biological Nanopore Kits
      • 8.2.1.2. Solid-State Nanopore Kits
    • 8.2.2. Sequencing By Synthesis Kits
  • 8.3. Template Preparation Kits
    • 8.3.1. Bridge PCR Kits
    • 8.3.2. Emulsion PCR Kits

9. NGS Kits Market, by Application

  • 9.1. Exome Sequencing
    • 9.1.1. Clinical Exome Sequencing
    • 9.1.2. Research Exome Sequencing
  • 9.2. Targeted Sequencing
    • 9.2.1. Hybridization Based Targeted Sequencing
    • 9.2.2. PCR Based Targeted Sequencing
  • 9.3. Transcriptome Sequencing
    • 9.3.1. Bulk RNA Sequencing
    • 9.3.2. Single Cell RNA Sequencing
  • 9.4. Whole Genome Sequencing

10. NGS Kits Market, by End User

  • 10.1. Academic Research Institute
    • 10.1.1. Government Research Centers
    • 10.1.2. University Laboratories
  • 10.2. Clinical Diagnostic Laboratories
    • 10.2.1. Hospital Diagnostic Laboratories
    • 10.2.2. Independent Diagnostic Laboratories
  • 10.3. Pharmaceutical Biotechnology Companies
    • 10.3.1. Biotechnology Startups
    • 10.3.2. Global Pharmaceutical Companies

11. NGS Kits Market, by Sequencing Technology

  • 11.1. Nanopore Sequencing
    • 11.1.1. Biological Nanopore
    • 11.1.2. Solid-State Nanopore
  • 11.2. Sequencing By Ligation
  • 11.3. Sequencing By Synthesis

12. NGS Kits Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. NGS Kits Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. NGS Kits Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Illumina, Inc.
    • 15.3.2. Thermo Fisher Scientific Inc.
    • 15.3.3. Roche Holding AG
    • 15.3.4. Danaher Corporation
    • 15.3.5. MGI Tech Co., Ltd.
    • 15.3.6. Agilent Technologies, Inc.
    • 15.3.7. PerkinElmer, Inc.
    • 15.3.8. Takara Bio Inc.
    • 15.3.9. Oxford Nanopore Technologies plc
    • 15.3.10. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS NGS KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL NGS KITS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NGS KITS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NGS KITS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NGS KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NGS KITS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NGS KITS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS NGS KITS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS NGS KITS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS NGS KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS NGS KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS NGS KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS NGS KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA NGS KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA NGS KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA NGS K